Abstract B190: GDC-0068 is a novel and selective Akt inhibitor that enhances the efficacy of FOLFOX in primary gastric cancer models

MLA

Elizabeth Punnoose, et al. “Abstract B190: GDC-0068 Is a Novel and Selective Akt Inhibitor That Enhances the Efficacy of FOLFOX in Primary Gastric Cancer Models.” Molecular Cancer Therapeutics, vol. 12, Nov. 2013, p. B190. EBSCOhost, https://doi.org/10.1158/1535-7163.targ-13-b190.

APA

Elizabeth Punnoose, Rebecca Hong, Ellen Ingalla, Deepak Sampath, Sandra Rost, Hartmut Koeppen, Heidi Savage, & Michelle Nannini. (2013). Abstract B190: GDC-0068 is a novel and selective Akt inhibitor that enhances the efficacy of FOLFOX in primary gastric cancer models. Molecular Cancer Therapeutics, 12, B190. https://doi.org/10.1158/1535-7163.targ-13-b190

Chicago

Elizabeth Punnoose, Rebecca Hong, Ellen Ingalla, Deepak Sampath, Sandra Rost, Hartmut Koeppen, Heidi Savage, and Michelle Nannini. 2013. “Abstract B190: GDC-0068 Is a Novel and Selective Akt Inhibitor That Enhances the Efficacy of FOLFOX in Primary Gastric Cancer Models.” Molecular Cancer Therapeutics 12 (November): B190. doi:10.1158/1535-7163.targ-13-b190.